Record Distributable Earnings and Strong Quarterly Results
GAAP net income of $2.0 billion in Q4; distributable earnings (DE) of $2.2 billion in Q4 ($1.75 per common share). Full-year DE grew ~20% to $7.1 billion, or $5.57 per share — the best year in the firm's history.
Exceptional Fundraising and Inflows
Inflows reached $71 billion in Q4 (the highest level in 3.5 years) and roughly $239–$240 billion for the full year, lifting momentum across institutional, private wealth, and insurance channels.
Assets Under Management Growth
AUM increased 13% year-over-year to a record of approximately $1.275 trillion (nearly $1.3 trillion), reflecting broad-based fundraising and product expansion.
Fee-Related Earnings and Management Fee Expansion
Q4 fee-related earnings (FRE) of $1.5 billion ($1.25 per share); management fees of $2.1 billion in Q4, up 11% YoY. Full-year FRE grew 9% to $5.7 billion and management fees rose 12% to $8.0 billion; FRE margin expanded over 100 basis points to a record full-year level.
Strong Investment Performance Across Key Businesses
Infrastructure appreciated 24% for 2025 (8.4% in Q4); corporate private equity up 14% for 2025 (5% in Q4); BXMA composite returned ~13% for 2025 and positive for 23 consecutive quarters.
Credit Platform Momentum and Performance
Total credit AUM of $520 billion, up 15% YoY; full-year non-investment grade private credit gross return 11% and real estate credit 17%. Direct lending realized losses were minimal at ~11 basis points over the last 12 months.
Private Wealth Channel Acceleration
Private wealth fundraising rose 53% YoY to $43 billion in 2025; private wealth AUM grew 16% YoY to over $300 billion. Notable products: BCRED gross sales $3.3 billion in Q4 and record $14 billion gross sales for full year; BXP annualized net return ~17% since inception and $18 billion AUM.
Deployment and Investment Activity
Invested $138 billion across the firm in 2025 (highest level in four years) and closed/signed eight privatizations including the $18 billion WholeLogic acquisition and the $7.2 billion Medline IPO, which traded +40% on day one.
Realizations and Monetizations Accelerating
Net realizations rose 59% YoY in Q4 to $957 million and increased ~50% for the full year to $2.1 billion, driven by several realizations (Resolution Life stake, Las Vegas asset, life sciences royalties, and BXMA crystallizations).